mRNA Unleashed: Manufacturing New Possibilities

mRNA therapeutics manufacturing has been a major industrial talking point since its development during the COVID-19 pandemic. Now that CDMOs are developing the technologies and the capacities to scale it up, we find out just how much potential there is in this sector.

01/11/2024

Subscribe for free:

Join our podcast with Dr. Eike Jöst from MilliporeSigma to learn how to accelerate your mRNA development and manufacturing program. Discover the benefits of their innovative PCR-based mRNA drug substance manufacturing process. Listen now!

Interviewee Biography

Eike Jöst, a principal scientist at MilliporeSigma, is responsible for developing innovations in mRNA manufacturing as part of the company’s Life Science Service offering.

His introduction to the world of mRNA began at Würzburg University around ten years ago where he focused on optogenetics to engineer light responsive cells. This field gained momentum nearly 20 years ago by injecting mRNA into cells, which enabled them to express photoreceptor genes. Now he helps to facilitate the possibilities by providing mRNA manufacturing capabilities that could lead to new, previously unimaginable, treatments.

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

All Episodes